Friday, February 19, 2021 Daily Archives

Transfection Reagents for Cell and Gene Therapy

by

Polysciences offers high-quality, R&D and cGMP grades of transfection reagents for the smooth transition from process development through clinical trials and commercial manufacturing of viral vectors/protein. Polysciences R&D grade PEI MAX has been used by academic and industry customers for over a decade and is one of the most cited transfected reagents. A few years ago Polysciences launched an easy to use liquid version of PEI MAX which is called Transporter 5 focusing on increased customer convenience. Both PEI MAX…

February 19, 2021

Novo Nordisk and Vertex update on rival diabetes cell therapy efforts

by

Novo Nordisk plans to file an IND for cell therapy for type 1 diabetes in the next few years, setting the stage for a battle with Vertex which aims to start Phase I/II trials of its candidate this year. Denmark’s Novo Nordisk shared details of its stem cell-based candidate during its Q4 call recently, explaining it will submit the therapy along with several investigation new drug (IND) applications over the next few years. CSO Mads Thomsen told analysts “The first…

February 19, 2021